First Trust Health Care AlphaDEX Fund (FXH) ETF Price Prediction 2027
Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation
Executive Forecast Synopsis (2027)
Synthesized fundamental, multiple & technical thesis for FXH
FXH Price Forecast 2027: Our AI models project that FXH stock will rise to approximately $160.87 by 2027. This represents a potential 17.7% growth from the current trading price of $136.68. The overall market sentiment for FXH is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.
About This ETF: FXH is the First Trust Health Care AlphaDEX Fund exchange-traded fund. Because an ETF tracks a basket of holdings rather than a single company, our 2027 forecast for FXH is driven primarily by price trend, momentum and volatility of the fund itself instead of company-level earnings estimates. Over the past 52 weeks the fund has traded between $104.53 and $143.96, and currently sits in the upper part of that range (82% of the way up). Investors typically use FXH to get diversified exposure to its underlying index in a single position, so the prediction above is best read as a view on the whole basket, not any individual constituent.
Technical Outlook: The stock is technically in a uptrend phase. The Relative Strength Index (RSI) is currently 55.3, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.
Quant Signal & Technical Posture
Composite equity rating reconciled with 1-year target trajectory
- Moving averages converging - equilibrium state
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.1592)
- Recent pattern: Doji - Indecision pattern
FXH Trajectory & Forecast Curve
Projected price curve from spot ($136.68) across 30D–3Y horizons
Term Structure of Price Targets
Constant-multiple earnings trajectory model
| Horizon | Target Price | Implied Return |
|---|---|---|
| 30 Days Near-Term | $138.62 | +1.4% |
| 90 Days 1 Quarter | $142.73 | +4.4% |
| 6 Months Medium-Term | $148.78 | +8.8% |
| 1 Year Base Model | $160.87 | +17.7% |
1-Year Scenario Distribution (Bull / Base / Bear)
Probability-weighted regime outcomes around the 12-month forecast horizon
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results
Fair Value & Core Fundamentals
PEG-adjusted intrinsic valuation & balance-sheet multiples
Technicals & Institutional Money Flow
Momentum oscillators, volume accumulation & key price levels
Positive Chaikin Money Flow and volume expansion indicate institutional accumulation on up-sessions.
Institutional Research Suite for FXH
Deep-dive valuation models, options chain analytics & head-to-head peer comparisons
Frequently Asked Questions (FXH 2027 Outlook)
What is the FXH stock price prediction for 2027?
Based on our AI analysis, FXH is predicted to reach $160.87 by 2027, representing a potential 17.7% increase from the current price of $136.68.
Is FXH stock a good buy right now?
Our analysis rates FXH as a HOLD (AI Quant Score 50.6/100) based on current technical and fundamental indicators. With a projected 17.7% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.
What is FXH 52-week high and low?
FXH has a 52-week high of $143.96 and a 52-week low of $104.53. The stock is currently trading 5.1% below its 52-week high.
What is the technical analysis for FXH?
FXH is currently in a uptrend trend. The RSI of 55.3 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.
What does the FXH ETF track?
FXH is the First Trust Health Care AlphaDEX Fund exchange-traded fund. Unlike a single stock, its price reflects a basket of holdings, so our 2027 forecast is based on the fund's own price trend, momentum and volatility rather than one company's earnings.